Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland
· Delayed Price · Currency is PLN 86.80
-0.60 (-0.69%)
Mar 9, 2026, 5:02 PM CET
WSE:CTX Revenue
Captor Therapeutics Spolka Akcyjna had revenue of 7.57M PLN in the twelve months ending September 30, 2025, down -60.89% year-over-year. In the year 2024, Captor Therapeutics Spolka Akcyjna had annual revenue of 15.83M with 19.88% growth.
Revenue (ttm)
7.57M
Revenue Growth
-60.89%
P/S Ratio
63.83
Revenue / Employee
83.19K
Employees
91
Market Cap
483.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15.83M | 2.62M | 19.88% |
| Dec 31, 2023 | 13.20M | 4.04M | 44.15% |
| Dec 31, 2022 | 9.16M | 5.17M | 129.75% |
| Dec 31, 2021 | 3.99M | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ryvu Therapeutics | 90.41M |
| BIOTON | 282.52M |
| Synthaverse | 71.76M |
| Molecure | 5.86M |
| Mabion | 14.81M |
| Poltreg | 250.00K |
| NanoGroup | -6.90K |
| Urteste | 1.80M |